semaglutide fda update Approves Oral as First GLP-1 Pill for Weight Loss Compounded Semaglutide: Legal & Safe

Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million

Victor-Costa, A

No matter what, protect your muscles

At semaglutide Chicago clinics and weight loss clinics near me , this treatment is rapidly gaining popularity for its effectiveness in managing weight